The following CME Controlled Substance Training activity is being offered by the SCMA in partnership with the South Carolina Center of Excellence in Addiction.

• NOTE: To register, you will be required to create a free SCMA account or log into your existing account.
• Participation Link: Your Microsoft Teams meeting link will be sent to you via email around 12 noon the day of the event.
• Questions? Please contact Necole Stinson at nstinson@scmedical.org

Taking on Pain Management Patients with Confidence: DEA Compliance, Documentation, and Practical Approaches to Continuity of Care
Date / Time: Wednesday, August 26, from 6 – 8 PM
Cost: The live webinar is FREE for all physicians

Presented by:

• Kelly S. Barth, DO, MUSC Health
• Leah Garland, Diversion Investigator with the Drug Enforcement Administration (DEA)
• Jillian Beck, Agent with the Bureau of Drug Control, South Carolina Department of Public Health

Course Details:
When a physician retires, dies, or can no longer prescribe controlled substances, patients can suddenly lose access to essential treatment. These disruptions create significant challenges for both patients and the physicians asked to assume their care. Join us as we help physicians confidently evaluate, treat, document, and manage patients affected by disruptions in care while maintaining compliance with state and federal requirements.

Hour 1: Patient Access Disruptions, Clinical Response, and Continuity of Care
Presenter: Kelly S. Barth, DO, MUSC Health

At the conclusion of this session, participants will be able to:

1. Recognize the clinical and patient safety challenges associated with disruptions in access to opioid and other controlled-substance prescribing due to clinician retirement, relocation, or regulatory action.
2. Conduct a comprehensive clinical assessment of patients transitioning from another controlled-substance prescriber to inform safe, evidence-based treatment decisions.
3. Develop evidence-informed treatment plans for patients transitioning from another pain or controlled-substance prescriber, including decisions to continue, modify, taper, discontinue, or transition opioid therapy.
4. Apply patient-centered communication and shared decision-making strategies to build therapeutic relationships, discuss treatment recommendations, and establish realistic expectations during transitions in care.
5. Identify when additional safety measures, including naloxone, buprenorphine, or referral for addiction evaluation and treatment, are appropriate.

Hour 2: Controlled Substance Regulatory Requirements
Presenters: Leah Garland, Diversion Investigator, DEA; and Jillian Beck, Agent, Bureau of Drug Control, South Carolina Department of Public Health

At the conclusion of this session, participants will be able to:

1. Describe the regulatory roles and responsibilities of the Drug Enforcement Administration (DEA) and the Department of Public Health (DPH) Bureau of Drug Control in overseeing controlled substances, including registration, inspection authority, and enforcement mechanisms.
2. Demonstrate proper controlled substance accountability and documentation practices, including procedures for identifying and reporting discrepancies or potential diversion.
3. Identify the legal and clinical requirements of a valid controlled substance prescription, including prescriber authority, patient-specific criteria, drug scheduling considerations, and mandatory elements needed to ensure compliance with federal and state regulations.

Disclosures:
None of the planners, faculty, or others in control of content of this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

No financial support received for this conference

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint-providership of the South Carolina Medical Association and South Carolina Center of Excellence in Addiction.

The South Carolina Medical Association designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The South Carolina Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

A portion of this educational activity was focused on controlled substance education, and as such, 2 Controlled Substance Training (CST) hours can be claimed by attendees.

Register Now